Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03017482 · ClinicalTrials.gov registry record
Clinical Startup of the 670G Closed Loop Insulin Delivery System
A clinical trial of Diabetes Mellitus, Type 1, sponsored by Stanford University.
- Completed
- Registry status
- 85
- Enrollment target
- 1
- Study location
NCT03017482 is a study of Diabetes Mellitus, Type 1 that has completed, run by Stanford University. The registered enrollment target is 85 participants, below the 1,265-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03017482, a study of Diabetes Mellitus, Type 1, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to track initiation and the first year of clinical use of the newly FDA approved 670G closed loop insulin delivery system by patients who have requested this system. Our goal is to evaluate our clinical approach to starting this newly approved system. Since the investigators are only following patients who have already decided to start the 670G, the investigator does not assign specific interventions to the subjects of the study; thus this is a Observational study.
Conditions Studied
Interventions
- DEVICE Medtronic 670G
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2017-07-15 |
| Est. Completion | 2019-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03017482
The ClinicalTrials.gov registry entry for NCT03017482 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,265-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (93% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 1 intervention - of which Medtronic 670G is the first listed.
NCT03017482 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03017482 about?
NCT03017482 is a clinical study titled "Clinical Startup of the 670G Closed Loop Insulin Delivery System". The purpose of this project is to track initiation and the first year of clinical use of the newly FDA approved 670G closed loop insulin delivery system by patients who have requested this system. Our goal is to evaluate our clinical approach to starting this newly approved system. Since the investi...
What is the current status of trial NCT03017482?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2017-07-15. Estimated completion is 2019-08-30.
What conditions does trial NCT03017482 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.
What interventions are being tested in trial NCT03017482?
The interventions under investigation include: Medtronic 670G (DEVICE).
Who is sponsoring clinical trial NCT03017482?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03017482 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes
RECRUITING · Phase 1
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Islet Transplantation in Type 1 Diabetic Kidney Allograft
RECRUITING · Phase 2
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
Regulation of Brain Glucose Metabolism in Type 1 Diabetes
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.